Annual Current Liabilities
$542.80 K
-$2.56 M-82.52%
December 31, 2023
Summary
- As of February 20, 2025, GDTC annual total current liabilities is $542.80 thousand, with the most recent change of -$2.56 million (-82.52%) on December 31, 2023.
- During the last 3 years, GDTC annual current liabilities has fallen by -$1.52 million (-73.65%).
- GDTC annual current liabilities is now -82.52% below its all-time high of $3.11 million, reached on December 31, 2022.
Performance
GDTC Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$263.80 K
-$279.00 K-51.40%
June 30, 2024
Summary
- As of February 20, 2025, GDTC quarterly total current liabilities is $263.80 thousand, with the most recent change of -$279.00 thousand (-51.40%) on June 30, 2024.
- Over the past year, GDTC quarterly current liabilities has stayed the same.
- GDTC quarterly current liabilities is now -91.51% below its all-time high of $3.11 million, reached on December 31, 2022.
Performance
GDTC Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
GDTC Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -82.5% | 0.0% |
| 3 y3 years | -73.7% | 0.0% |
| 5 y5 years | -73.7% | 0.0% |
GDTC Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.5% | at low | -91.5% | +13.6% |
| 5 y | 5-year | -82.5% | at low | -91.5% | +13.6% |
| alltime | all time | -82.5% | at low | -91.5% | +13.6% |
CytoMed Therapeutics Limited Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $263.80 K(-51.4%) |
| Dec 2023 | $542.80 K(-82.5%) | $542.80 K(+133.8%) |
| Jun 2023 | - | $232.20 K(-92.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $3.11 M(+43.0%) | $3.11 M(+40.7%) |
| Jun 2022 | - | $2.21 M(+1.7%) |
| Dec 2021 | $2.17 M(+5.4%) | $2.17 M |
| Dec 2020 | $2.06 M | - |
FAQ
- What is CytoMed Therapeutics Limited annual total current liabilities?
- What is the all time high annual current liabilities for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual current liabilities year-on-year change?
- What is CytoMed Therapeutics Limited quarterly total current liabilities?
- What is the all time high quarterly current liabilities for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited quarterly current liabilities year-on-year change?
What is CytoMed Therapeutics Limited annual total current liabilities?
The current annual current liabilities of GDTC is $542.80 K
What is the all time high annual current liabilities for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual total current liabilities is $3.11 M
What is CytoMed Therapeutics Limited annual current liabilities year-on-year change?
Over the past year, GDTC annual total current liabilities has changed by -$2.56 M (-82.52%)
What is CytoMed Therapeutics Limited quarterly total current liabilities?
The current quarterly current liabilities of GDTC is $263.80 K
What is the all time high quarterly current liabilities for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high quarterly total current liabilities is $3.11 M
What is CytoMed Therapeutics Limited quarterly current liabilities year-on-year change?
Over the past year, GDTC quarterly total current liabilities has changed by $0.00 (0.00%)